Adma Biologics ADMA
NASDAQ ADMA
$9.96 -0.16 (-1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Operating Income (2011 - 2026)

Updated

Adma Biologics' Operating Income came in at $52.45 million for Q2 2026, up 22.5% from $42.8 million a year earlier but down 10.0% from the prior quarter.

Analysis

Adma Biologics (ADMA) Operating Income (2011 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Adma Biologics reported Operating Income of $224.48 million, up 44.2% year-over-year; for FY2025, it was $191.44 million, up 37.7% from FY2024.

  • Going back by year, Operating Income was $138.98 million in FY2024 (+542.5%), $21.63 million in FY2023, -$39.37 million in FY2022 and -$58.37 million in FY2021.
  • The five-year range for quarterly Operating Income is -$14.82 million (Q1 2022) to $62.75 million (Q4 2025).
  • Year-over-year, Operating Income has increased for eight consecutive quarters, with growth averaging 97.1% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Operating Income ranged from 9.2% (Q2 2025) to 356.4% (Q3 2024).
  • Business Quant data shows ADMA's Operating Income at $58.27 million (Q1 2026), $62.75 million (Q4 2025) and $51.01 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 7.14 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 6.43 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 3.16 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -10.39 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.25 Bn
10 Adma Biologics 2.28 Bn 1.86 Bn 86.28 Mn 52.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.45 Mn
Mar 31, 2026 58.27 Mn
Dec 31, 2025 62.75 Mn
Sep 30, 2025 51.01 Mn
Jun 30, 2025 42.80 Mn
Mar 31, 2025 34.88 Mn
Dec 31, 2024 38.32 Mn
Sep 30, 2024 39.64 Mn
Jun 30, 2024 39.20 Mn
Mar 31, 2024 21.82 Mn
Dec 31, 2023 14.23 Mn
Sep 30, 2023 8.69 Mn
Jun 30, 2023 -473,000.00
Mar 31, 2023 -813,000.00
Dec 31, 2022 -6.06 Mn
Sep 30, 2022 -9.32 Mn
Jun 30, 2022 -9.17 Mn
Mar 31, 2022 -14.82 Mn
Dec 31, 2021 -13.19 Mn
Sep 30, 2021 -14.44 Mn
API Access

Adma Biologics Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=ADMA&period=max&api_key=YOUR_API_KEY